AI integration advances in microbiology and computational pathology

Artificial intelligence is increasingly being integrated into healthcare, moving from simple algorithms to complex systems designed for specialized medical workflows.

In the field of microbiology, Clever Culture Systems (ASX:CC5) has developed the APAS Independence system. This FDA-cleared technology uses AI and computer vision to automate the imaging, analysis, and interpretation of microbiology culture plates. The company’s competitive advantage is attributed to its integration of proprietary intellectual property, specialist knowledge, and regulatory expertise, serving major pharmaceutical clients including AstraZeneca, Pfizer, and Novo Nordisk.

Simultaneously, research into computational pathology is shifting toward agent-based systems. Rather than using static models that provide a single classification, new approaches aim to use large language models (LLMs) and vision-language models (VLMs) to mimic the sequential, evidence-driven diagnostic process used by human pathologists. These intelligent agents are designed to handle complex tasks such as slide navigation, diagnostic reasoning, and report generation through a dynamic, revisable workflow.